To investigate whether the conditioned medium of menstrual blood-derived endometrial stem cell could effectively relieve the symptoms of NPC1, researchers employed the CRISPR-Cas9 technique to successfully create a Npc1 gene knockout N2a cell line.
[Metabolic Brain Disease]